|
|
| Line 1: |
Line 1: |
| {{Congestive heart failure}}
| |
| {{CMG}}
| |
|
| |
|
| ==Overview==
| |
| * Cardiac transplantation is reserved for patients with end-stage congestive heart failure despite all interventions.
| |
| * 80% 1 year survival, and 60% 5 year survival.
| |
| * Lifelong immunosuppressive therapy to prevent (or postpone) rejection, increased risk for opportunistic infections and malignancies.
| |
|
| |
|
| ===AHA/ACC Guidelines: Indications for heart transplantation:===
| | #redirect:[[Heart transplantation]] |
| *Any hemodynamic compromise due to heart failure.
| |
| *Requiring IV inotropic support to maintain adequate organ perfusion.
| |
| *Peak Vo2 <10 ml/kg/min.
| |
| *NYHA Class IV symptoms not amenable to any other intervention.
| |
| *Recurrence of symptomatic ventricular arrhythmias refractory to all therapeutic intervention.
| |
| | |
| ==References==
| |
| {{Reflist|2}}
| |
| | |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |
| | |
| [[Category:Disease]] | |
| [[Category:Cardiology]]
| |
| [[Category:Emergency medicine]]
| |
| [[Category:Up-To-Date]]
| |
| [[Category:Up-To-Date cardiology]]
| |